A
Agilent Technologies, Inc. · Healthcare · Medical - Diagnostics & Research
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q2 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 166 | +3 | 195.87M | $26.02B | +9 | −5 |
| Q1 2026 | 165 | -3 | 181.10M | $20.68B | +3 | −7 |
| Q4 2025 | 167 | +1 | 200.20M | $27.23B | +3 | −1 |
| Q3 2025 | 22 | +2 | 109.95M | $14.10B | +3 | −2 |
| Q2 2025 | 18 | -1 | 102.37M | $12.08B | — | −1 |
| Q1 2025 | 16 | -1 | 41.13M | $4.81B | — | −1 |
| Q4 2024 | 17 | +1 | 41.24M | $5.54B | +2 | −1 |
| Q3 2024 | 15 | -1 | 26.67M | $3.96B | +1 | −2 |
| Q2 2024 | 16 | — | 29.82M | $3.86B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Management ✦ | 9.53M | — | $1.24B | 0.2% | n/c | 1 | SEC ↗ |
| 2 | Wellington Management ✦ | 9.53M | — | $1.24B | 0.2% | n/c | 1 | SEC ↗ |
| 3 | Wellington Management ✦ | 9.53M | — | $1.24B | 0.2% | n/c | 1 | SEC ↗ |
| 4 | Wellington Management ✦ | 9.53M | — | $1.24B | 0.2% | n/c | 1 | SEC ↗ |
| 5 | Wellington Management ✦ | 9.53M | — | $1.24B | 0.2% | n/c | 1 | SEC ↗ |
| 6 | Wellington Management ✦ | 9.53M | — | $1.24B | 0.2% | n/c | 1 | SEC ↗ |
| 7 | Wellington Management ✦ | 9.53M | — | $1.24B | 0.2% | n/c | 1 | SEC ↗ |
| 8 | Wellington Management ✦ | 9.53M | — | $1.24B | 0.2% | n/c | 1 | SEC ↗ |
| 9 | Geode Capital Management ✦ (passive) | 6.92M | — | $894.40M | 0.1% | n/c | 1 | SEC ↗ |
| 10 | Geode Capital Management ✦ (passive) | 6.92M | — | $894.40M | 0.1% | n/c | 1 | SEC ↗ |
| 11 | Norges Bank ✦ (passive) | 3.11M | — | $402.64M | 0.1% | n/c | 1 | SEC ↗ |
| 12 | T. Rowe Price ✦ | 2.91M | — | $376.65M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | T. Rowe Price ✦ | 2.91M | — | $376.65M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | PRIMECAP Management ✦ | 1.96M | — | $253.63M | 0.2% | n/c | 1 | SEC ↗ |
| 15 | Harris Associates (Oakmark) ✦ | 1.89M | — | $244.85M | 0.4% | n/c | 1 | SEC ↗ |
| 16 | Citadel Advisors ✦ | 992.33K | — | $128.64M | 0.1% | n/c | 1 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 992.33K | — | $128.64M | 0.1% | n/c | 1 | SEC ↗ |
| 18 | Marshall Wace ✦ | 957.13K | — | $124.07M | 0.2% | n/c | 1 | SEC ↗ |
| 19 | Millennium Management ✦ | 875.15K | — | $113.45M | 0.1% | n/c | 1 | SEC ↗ |
| 20 | Point72 Asset Management ✦ | 215.76K | — | $27.97M | 0.1% | n/c | 1 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 184.78K | — | $23.95M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 184.78K | — | $23.95M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 184.78K | — | $23.95M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | Adage Capital Partners ✦ | 131.09K | — | $16.99M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | Soros Fund Management ✦ | 100.00K | — | $12.96M | 0.4% | n/c | 1 | SEC ↗ |
| 26 | Two Sigma Investments ✦ | 26.28K | — | $3.41M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | Gotham Asset Management ✦ | 22.00K | — | $2.85M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | D. E. Shaw & Co. ✦ | 4.32K | — | $559,742 | 0.0% | n/c | 1 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| No tracked exits this quarter. |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 1 holders, 1.80K shares, $205 reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.